The global market for Cancer Early Screening NGS Testing Platform was valued at US$ 527 million in the year 2024 and is projected to reach a revised size of US$ 1381 million by 2031, growing at a CAGR of 15.0% during the forecast period.

Cancer Early Screening NGS Testing Platform Market

There are nearly 20 million new cancer cases and nearly 10 million cancer deaths worldwide each year, and the cancer prevalence in my country is at an internationally medium-to-high level. WHO believes that one-third of cancers can be cured through early detection. Compared with advanced cancer, early cancer has not metastasized and is easier to be eliminated through surgery, radiotherapy, chemotherapy and other means. Treatment intervention in the early stages of cancer can help increase the patient's chance of survival, reduce pain and reduce economic burden. At present, there is no effective means to treat advanced cancer. Early detection and early treatment are considered to be the most effective means of treating cancer. Therefore, improving the sensitivity of tumor detection is of great significance to improving the survival rate of cancer patients, among which early screening and early diagnosis will play an important role.

There are two main technical routes for early screening products in NGS. One is cfDNA methylation sequencing based on gene methylation characteristics, and the other is whole genome sequencing based on cfDNA fragmentation end characteristics and CNV. Methylation-based NGS technology can usually be divided into capture method or multiple PCR to obtain the target area through machine learning and model analysis to obtain early tumor weak signals. Detection based on cfDNA fragmentation end characteristics and CNV is usually based on different types of genome library construction, and AI algorithm analysis is performed on markers to capture the differences in early weak signals of tumors.

North American market for Cancer Early Screening NGS Testing Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cancer Early Screening NGS Testing Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cancer Early Screening NGS Testing Platform in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cancer Early Screening NGS Testing Platform include GRAIL, Exact Sciences, Guardanthealth, Akery, Foundation Medicine, Illumina, Inc., Hangzhou New Horizon Health Technology Co., Ltd., Berry Oncology Co., Ltd., Genetron Health (Beijing) Co., Ltd., Yeasen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Early Screening NGS Testing Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Early Screening NGS Testing Platform.

The Cancer Early Screening NGS Testing Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Early Screening NGS Testing Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Early Screening NGS Testing Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Early Screening NGS Testing Platform Market Report

Report Metric	Details
Report Name	Cancer Early Screening NGS Testing Platform Market
Accounted market size in year	US$ 527 million
Forecasted market size in 2031	US$ 1381 million
CAGR	15.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	cfDNA Methylation Sequencing Whole Genome Sequencing Based On cfDNA Fragmentation End Characteristics and CNV
Segment by Application	Hospitals Clinics Medical Laboratories University Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GRAIL, Exact Sciences, Guardanthealth, Akery, Foundation Medicine, Illumina, Inc., Hangzhou New Horizon Health Technology Co., Ltd., Berry Oncology Co., Ltd., Genetron Health (Beijing) Co., Ltd., Yeasen, Guangzhou Burning Rock Dx Co., Ltd., BGI Genomics Co., Ltd., Jiangsu Huayuan Biotechnology Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Early Screening NGS Testing Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Early Screening NGS Testing Platform Market growing?

Ans: The Cancer Early Screening NGS Testing Platform Market witnessing a CAGR of 15.0% during the forecast period 2025-2031.

What is the Cancer Early Screening NGS Testing Platform Market size in 2031?

Ans: The Cancer Early Screening NGS Testing Platform Market size in 2031 will be US$ 1381 million.

Who are the main players in the Cancer Early Screening NGS Testing Platform Market report?

Ans: The main players in the Cancer Early Screening NGS Testing Platform Market are GRAIL, Exact Sciences, Guardanthealth, Akery, Foundation Medicine, Illumina, Inc., Hangzhou New Horizon Health Technology Co., Ltd., Berry Oncology Co., Ltd., Genetron Health (Beijing) Co., Ltd., Yeasen, Guangzhou Burning Rock Dx Co., Ltd., BGI Genomics Co., Ltd., Jiangsu Huayuan Biotechnology Co., Ltd.

What are the Application segmentation covered in the Cancer Early Screening NGS Testing Platform Market report?

Ans: The Applications covered in the Cancer Early Screening NGS Testing Platform Market report are Hospitals, Clinics, Medical Laboratories, University Laboratories, Others

What are the Type segmentation covered in the Cancer Early Screening NGS Testing Platform Market report?

Ans: The Types covered in the Cancer Early Screening NGS Testing Platform Market report are cfDNA Methylation Sequencing, Whole Genome Sequencing Based On cfDNA Fragmentation End Characteristics and CNV

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Early Screening NGS Testing Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 cfDNA Methylation Sequencing

1.2.3 Whole Genome Sequencing Based On cfDNA Fragmentation End Characteristics and CNV

1.3 Market by Application

1.3.1 Global Cancer Early Screening NGS Testing Platform Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Medical Laboratories

1.3.5 University Laboratories

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Early Screening NGS Testing Platform Market Perspective (2020-2031)

2.2 Global Cancer Early Screening NGS Testing Platform Growth Trends by Region

2.2.1 Global Cancer Early Screening NGS Testing Platform Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Early Screening NGS Testing Platform Historic Market Size by Region (2020-2025)

2.2.3 Cancer Early Screening NGS Testing Platform Forecasted Market Size by Region (2026-2031)

2.3 Cancer Early Screening NGS Testing Platform Market Dynamics

2.3.1 Cancer Early Screening NGS Testing Platform Industry Trends

2.3.2 Cancer Early Screening NGS Testing Platform Market Drivers

2.3.3 Cancer Early Screening NGS Testing Platform Market Challenges

2.3.4 Cancer Early Screening NGS Testing Platform Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Early Screening NGS Testing Platform Players by Revenue

3.1.1 Global Top Cancer Early Screening NGS Testing Platform Players by Revenue (2020-2025)

3.1.2 Global Cancer Early Screening NGS Testing Platform Revenue Market Share by Players (2020-2025)

3.2 Global Top Cancer Early Screening NGS Testing Platform Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Early Screening NGS Testing Platform Revenue

3.4 Global Cancer Early Screening NGS Testing Platform Market Concentration Ratio

3.4.1 Global Cancer Early Screening NGS Testing Platform Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Early Screening NGS Testing Platform Revenue in 2024

3.5 Global Key Players of Cancer Early Screening NGS Testing Platform Head office and Area Served

3.6 Global Key Players of Cancer Early Screening NGS Testing Platform, Product and Application

3.7 Global Key Players of Cancer Early Screening NGS Testing Platform, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Early Screening NGS Testing Platform Breakdown Data by Type

4.1 Global Cancer Early Screening NGS Testing Platform Historic Market Size by Type (2020-2025)

4.2 Global Cancer Early Screening NGS Testing Platform Forecasted Market Size by Type (2026-2031)

5 Cancer Early Screening NGS Testing Platform Breakdown Data by Application

5.1 Global Cancer Early Screening NGS Testing Platform Historic Market Size by Application (2020-2025)

5.2 Global Cancer Early Screening NGS Testing Platform Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cancer Early Screening NGS Testing Platform Market Size (2020-2031)

6.2 North America Cancer Early Screening NGS Testing Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Early Screening NGS Testing Platform Market Size by Country (2020-2025)

6.4 North America Cancer Early Screening NGS Testing Platform Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Early Screening NGS Testing Platform Market Size (2020-2031)

7.2 Europe Cancer Early Screening NGS Testing Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Early Screening NGS Testing Platform Market Size by Country (2020-2025)

7.4 Europe Cancer Early Screening NGS Testing Platform Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Early Screening NGS Testing Platform Market Size (2020-2031)

8.2 Asia-Pacific Cancer Early Screening NGS Testing Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Early Screening NGS Testing Platform Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Early Screening NGS Testing Platform Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Early Screening NGS Testing Platform Market Size (2020-2031)

9.2 Latin America Cancer Early Screening NGS Testing Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Early Screening NGS Testing Platform Market Size by Country (2020-2025)

9.4 Latin America Cancer Early Screening NGS Testing Platform Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Early Screening NGS Testing Platform Market Size (2020-2031)

10.2 Middle East & Africa Cancer Early Screening NGS Testing Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Early Screening NGS Testing Platform Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Early Screening NGS Testing Platform Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GRAIL

11.1.1 GRAIL Company Details

11.1.2 GRAIL Business Overview

11.1.3 GRAIL Cancer Early Screening NGS Testing Platform Introduction

11.1.4 GRAIL Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.1.5 GRAIL Recent Development

11.2 Exact Sciences

11.2.1 Exact Sciences Company Details

11.2.2 Exact Sciences Business Overview

11.2.3 Exact Sciences Cancer Early Screening NGS Testing Platform Introduction

11.2.4 Exact Sciences Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.2.5 Exact Sciences Recent Development

11.3 Guardanthealth

11.3.1 Guardanthealth Company Details

11.3.2 Guardanthealth Business Overview

11.3.3 Guardanthealth Cancer Early Screening NGS Testing Platform Introduction

11.3.4 Guardanthealth Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.3.5 Guardanthealth Recent Development

11.4 Akery

11.4.1 Akery Company Details

11.4.2 Akery Business Overview

11.4.3 Akery Cancer Early Screening NGS Testing Platform Introduction

11.4.4 Akery Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.4.5 Akery Recent Development

11.5 Foundation Medicine

11.5.1 Foundation Medicine Company Details

11.5.2 Foundation Medicine Business Overview

11.5.3 Foundation Medicine Cancer Early Screening NGS Testing Platform Introduction

11.5.4 Foundation Medicine Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.5.5 Foundation Medicine Recent Development

11.6 Illumina, Inc.

11.6.1 Illumina, Inc. Company Details

11.6.2 Illumina, Inc. Business Overview

11.6.3 Illumina, Inc. Cancer Early Screening NGS Testing Platform Introduction

11.6.4 Illumina, Inc. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.6.5 Illumina, Inc. Recent Development

11.7 Hangzhou New Horizon Health Technology Co., Ltd.

11.7.1 Hangzhou New Horizon Health Technology Co., Ltd. Company Details

11.7.2 Hangzhou New Horizon Health Technology Co., Ltd. Business Overview

11.7.3 Hangzhou New Horizon Health Technology Co., Ltd. Cancer Early Screening NGS Testing Platform Introduction

11.7.4 Hangzhou New Horizon Health Technology Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.7.5 Hangzhou New Horizon Health Technology Co., Ltd. Recent Development

11.8 Berry Oncology Co., Ltd.

11.8.1 Berry Oncology Co., Ltd. Company Details

11.8.2 Berry Oncology Co., Ltd. Business Overview

11.8.3 Berry Oncology Co., Ltd. Cancer Early Screening NGS Testing Platform Introduction

11.8.4 Berry Oncology Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.8.5 Berry Oncology Co., Ltd. Recent Development

11.9 Genetron Health (Beijing) Co., Ltd.

11.9.1 Genetron Health (Beijing) Co., Ltd. Company Details

11.9.2 Genetron Health (Beijing) Co., Ltd. Business Overview

11.9.3 Genetron Health (Beijing) Co., Ltd. Cancer Early Screening NGS Testing Platform Introduction

11.9.4 Genetron Health (Beijing) Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.9.5 Genetron Health (Beijing) Co., Ltd. Recent Development

11.10 Yeasen

11.10.1 Yeasen Company Details

11.10.2 Yeasen Business Overview

11.10.3 Yeasen Cancer Early Screening NGS Testing Platform Introduction

11.10.4 Yeasen Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.10.5 Yeasen Recent Development

11.11 Guangzhou Burning Rock Dx Co., Ltd.

11.11.1 Guangzhou Burning Rock Dx Co., Ltd. Company Details

11.11.2 Guangzhou Burning Rock Dx Co., Ltd. Business Overview

11.11.3 Guangzhou Burning Rock Dx Co., Ltd. Cancer Early Screening NGS Testing Platform Introduction

11.11.4 Guangzhou Burning Rock Dx Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.11.5 Guangzhou Burning Rock Dx Co., Ltd. Recent Development

11.12 BGI Genomics Co., Ltd.

11.12.1 BGI Genomics Co., Ltd. Company Details

11.12.2 BGI Genomics Co., Ltd. Business Overview

11.12.3 BGI Genomics Co., Ltd. Cancer Early Screening NGS Testing Platform Introduction

11.12.4 BGI Genomics Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.12.5 BGI Genomics Co., Ltd. Recent Development

11.13 Jiangsu Huayuan Biotechnology Co., Ltd.

11.13.1 Jiangsu Huayuan Biotechnology Co., Ltd. Company Details

11.13.2 Jiangsu Huayuan Biotechnology Co., Ltd. Business Overview

11.13.3 Jiangsu Huayuan Biotechnology Co., Ltd. Cancer Early Screening NGS Testing Platform Introduction

11.13.4 Jiangsu Huayuan Biotechnology Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025)

11.13.5 Jiangsu Huayuan Biotechnology Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Hangzhou New Horizon Health Technology Co., Ltd.

Berry Oncology Co., Ltd.

Genetron Health (Beijing) Co., Ltd.

Yeasen

Guangzhou Burning Rock Dx Co., Ltd.

BGI Genomics Co.,Ltd.

Jiangsu Huayuan Biotechnology Co., Ltd.

List of Tables

Table 1. Global Cancer Early Screening NGS Testing Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of cfDNA Methylation Sequencing

Table 3. Key Players of Whole Genome Sequencing Based On cfDNA Fragmentation End Characteristics and CNV

Table 4. Global Cancer Early Screening NGS Testing Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Cancer Early Screening NGS Testing Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Cancer Early Screening NGS Testing Platform Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Cancer Early Screening NGS Testing Platform Market Share by Region (2020-2025)

Table 8. Global Cancer Early Screening NGS Testing Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Cancer Early Screening NGS Testing Platform Market Share by Region (2026-2031)

Table 10. Cancer Early Screening NGS Testing Platform Market Trends

Table 11. Cancer Early Screening NGS Testing Platform Market Drivers

Table 12. Cancer Early Screening NGS Testing Platform Market Challenges

Table 13. Cancer Early Screening NGS Testing Platform Market Restraints

Table 14. Global Cancer Early Screening NGS Testing Platform Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Cancer Early Screening NGS Testing Platform Market Share by Players (2020-2025)

Table 16. Global Top Cancer Early Screening NGS Testing Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Screening NGS Testing Platform as of 2024)

Table 17. Ranking of Global Top Cancer Early Screening NGS Testing Platform Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Cancer Early Screening NGS Testing Platform Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Cancer Early Screening NGS Testing Platform, Headquarters and Area Served

Table 20. Global Key Players of Cancer Early Screening NGS Testing Platform, Product and Application

Table 21. Global Key Players of Cancer Early Screening NGS Testing Platform, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cancer Early Screening NGS Testing Platform Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Cancer Early Screening NGS Testing Platform Revenue Market Share by Type (2020-2025)

Table 25. Global Cancer Early Screening NGS Testing Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Cancer Early Screening NGS Testing Platform Revenue Market Share by Type (2026-2031)

Table 27. Global Cancer Early Screening NGS Testing Platform Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Cancer Early Screening NGS Testing Platform Revenue Market Share by Application (2020-2025)

Table 29. Global Cancer Early Screening NGS Testing Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Cancer Early Screening NGS Testing Platform Revenue Market Share by Application (2026-2031)

Table 31. North America Cancer Early Screening NGS Testing Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Cancer Early Screening NGS Testing Platform Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Cancer Early Screening NGS Testing Platform Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Cancer Early Screening NGS Testing Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Cancer Early Screening NGS Testing Platform Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Cancer Early Screening NGS Testing Platform Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Cancer Early Screening NGS Testing Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Cancer Early Screening NGS Testing Platform Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Cancer Early Screening NGS Testing Platform Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Cancer Early Screening NGS Testing Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Cancer Early Screening NGS Testing Platform Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Cancer Early Screening NGS Testing Platform Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Cancer Early Screening NGS Testing Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Cancer Early Screening NGS Testing Platform Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Cancer Early Screening NGS Testing Platform Market Size by Country (2026-2031) & (US$ Million)

Table 46. GRAIL Company Details

Table 47. GRAIL Business Overview

Table 48. GRAIL Cancer Early Screening NGS Testing Platform Product

Table 49. GRAIL Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 50. GRAIL Recent Development

Table 51. Exact Sciences Company Details

Table 52. Exact Sciences Business Overview

Table 53. Exact Sciences Cancer Early Screening NGS Testing Platform Product

Table 54. Exact Sciences Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 55. Exact Sciences Recent Development

Table 56. Guardanthealth Company Details

Table 57. Guardanthealth Business Overview

Table 58. Guardanthealth Cancer Early Screening NGS Testing Platform Product

Table 59. Guardanthealth Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 60. Guardanthealth Recent Development

Table 61. Akery Company Details

Table 62. Akery Business Overview

Table 63. Akery Cancer Early Screening NGS Testing Platform Product

Table 64. Akery Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 65. Akery Recent Development

Table 66. Foundation Medicine Company Details

Table 67. Foundation Medicine Business Overview

Table 68. Foundation Medicine Cancer Early Screening NGS Testing Platform Product

Table 69. Foundation Medicine Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 70. Foundation Medicine Recent Development

Table 71. Illumina, Inc. Company Details

Table 72. Illumina, Inc. Business Overview

Table 73. Illumina, Inc. Cancer Early Screening NGS Testing Platform Product

Table 74. Illumina, Inc. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 75. Illumina, Inc. Recent Development

Table 76. Hangzhou New Horizon Health Technology Co., Ltd. Company Details

Table 77. Hangzhou New Horizon Health Technology Co., Ltd. Business Overview

Table 78. Hangzhou New Horizon Health Technology Co., Ltd. Cancer Early Screening NGS Testing Platform Product

Table 79. Hangzhou New Horizon Health Technology Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 80. Hangzhou New Horizon Health Technology Co., Ltd. Recent Development

Table 81. Berry Oncology Co., Ltd. Company Details

Table 82. Berry Oncology Co., Ltd. Business Overview

Table 83. Berry Oncology Co., Ltd. Cancer Early Screening NGS Testing Platform Product

Table 84. Berry Oncology Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 85. Berry Oncology Co., Ltd. Recent Development

Table 86. Genetron Health (Beijing) Co., Ltd. Company Details

Table 87. Genetron Health (Beijing) Co., Ltd. Business Overview

Table 88. Genetron Health (Beijing) Co., Ltd. Cancer Early Screening NGS Testing Platform Product

Table 89. Genetron Health (Beijing) Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 90. Genetron Health (Beijing) Co., Ltd. Recent Development

Table 91. Yeasen Company Details

Table 92. Yeasen Business Overview

Table 93. Yeasen Cancer Early Screening NGS Testing Platform Product

Table 94. Yeasen Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 95. Yeasen Recent Development

Table 96. Guangzhou Burning Rock Dx Co., Ltd. Company Details

Table 97. Guangzhou Burning Rock Dx Co., Ltd. Business Overview

Table 98. Guangzhou Burning Rock Dx Co., Ltd. Cancer Early Screening NGS Testing Platform Product

Table 99. Guangzhou Burning Rock Dx Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 100. Guangzhou Burning Rock Dx Co., Ltd. Recent Development

Table 101. BGI Genomics Co., Ltd. Company Details

Table 102. BGI Genomics Co., Ltd. Business Overview

Table 103. BGI Genomics Co., Ltd. Cancer Early Screening NGS Testing Platform Product

Table 104. BGI Genomics Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 105. BGI Genomics Co., Ltd. Recent Development

Table 106. Jiangsu Huayuan Biotechnology Co., Ltd. Company Details

Table 107. Jiangsu Huayuan Biotechnology Co., Ltd. Business Overview

Table 108. Jiangsu Huayuan Biotechnology Co., Ltd. Cancer Early Screening NGS Testing Platform Product

Table 109. Jiangsu Huayuan Biotechnology Co., Ltd. Revenue in Cancer Early Screening NGS Testing Platform Business (2020-2025) & (US$ Million)

Table 110. Jiangsu Huayuan Biotechnology Co., Ltd. Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Cancer Early Screening NGS Testing Platform Picture

Figure 2. Global Cancer Early Screening NGS Testing Platform Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Early Screening NGS Testing Platform Market Share by Type: 2024 VS 2031

Figure 4. cfDNA Methylation Sequencing Features

Figure 5. Whole Genome Sequencing Based On cfDNA Fragmentation End Characteristics and CNV Features

Figure 6. Global Cancer Early Screening NGS Testing Platform Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Cancer Early Screening NGS Testing Platform Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Medical Laboratories Case Studies

Figure 11. University Laboratories Case Studies

Figure 12. Others Case Studies

Figure 13. Cancer Early Screening NGS Testing Platform Report Years Considered

Figure 14. Global Cancer Early Screening NGS Testing Platform Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Cancer Early Screening NGS Testing Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Cancer Early Screening NGS Testing Platform Market Share by Region: 2024 VS 2031

Figure 17. Global Cancer Early Screening NGS Testing Platform Market Share by Players in 2024

Figure 18. Global Cancer Early Screening NGS Testing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Cancer Early Screening NGS Testing Platform Revenue in 2024

Figure 20. North America Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Cancer Early Screening NGS Testing Platform Market Share by Country (2020-2031)

Figure 22. United States Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Cancer Early Screening NGS Testing Platform Market Share by Country (2020-2031)

Figure 26. Germany Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Cancer Early Screening NGS Testing Platform Market Share by Region (2020-2031)

Figure 34. China Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Cancer Early Screening NGS Testing Platform Market Share by Country (2020-2031)

Figure 42. Mexico Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Cancer Early Screening NGS Testing Platform Market Share by Country (2020-2031)

Figure 46. Turkey Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Cancer Early Screening NGS Testing Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. GRAIL Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 50. Exact Sciences Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 51. Guardanthealth Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 52. Akery Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 53. Foundation Medicine Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 54. Illumina, Inc. Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 55. Hangzhou New Horizon Health Technology Co., Ltd. Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 56. Berry Oncology Co., Ltd. Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 57. Genetron Health (Beijing) Co., Ltd. Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 58. Yeasen Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 59. Guangzhou Burning Rock Dx Co., Ltd. Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 60. BGI Genomics Co., Ltd. Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 61. Jiangsu Huayuan Biotechnology Co., Ltd. Revenue Growth Rate in Cancer Early Screening NGS Testing Platform Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32T20006

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0Q20500

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-18V16958

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cancer Early Screening NGS Testing Platform Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-29B19202

Global Cancer Early Screening NGS Testing Platform Market Research Report 2025

FEATURED COMPANIES

Cancer Early Screening NGS Testing Platform Market Size

Cancer Early Screening NGS Testing Platform Market

Scope of Cancer Early Screening NGS Testing Platform Market Report

Chapter Outline

FAQ for this report

How fast is Cancer Early Screening NGS Testing Platform Market growing?

What is the Cancer Early Screening NGS Testing Platform Market size in 2031?

Who are the main players in the Cancer Early Screening NGS Testing Platform Market report?

What are the Application segmentation covered in the Cancer Early Screening NGS Testing Platform Market report?

What are the Type segmentation covered in the Cancer Early Screening NGS Testing Platform Market report?

FEATURED COMPANIES

RELATED REPORTS